blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2766350

EP2766350 - SELECTIVE ANDROGEN RECEPTOR MODULATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.02.2018
Database last updated on 11.04.2026
FormerThe patent has been granted
Status updated on  03.03.2017
FormerGrant of patent is intended
Status updated on  22.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285 / US
[2014/34]
Inventor(s)01 / JADHAV, Prabhakar Kondaji
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288 / US
02 / SAEED, Ashraf
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288 / US
03 / GREEN, Jonathan Edward
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288 / US
04 / KRISHNAN, Venkatesh
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288 / US
05 / MATTHEWS, Donald Paul
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288 / US
06 / STEPHENSON, Gregory Alan
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288 / US
 [2014/34]
Representative(s)Smith, Andrew George
Eli Lilly and Company Limited
8 Arlington Square West Downshire Way
Bracknell, Berkshire RG12 1PU / GB
[N/P]
Former [2014/34]Smith, Andrew George
Eli Lilly and Company Limited European Patent Operations Lilly Research Centre Erl Wood Manor
Windlesham, Surrey GU20 6PH / GB
Application number, filing date12775406.705.10.2012
[2017/14]
WO2012US58824
Priority number, dateUS201161546711P13.10.2011         Original published format: US 201161546711 P
[2014/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013055577
Date:18.04.2013
Language:EN
[2013/16]
Type: A1 Application with search report 
No.:EP2766350
Date:20.08.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 18.04.2013 takes the place of the publication of the European patent application.
[2014/34]
Type: B1 Patent specification 
No.:EP2766350
Date:05.04.2017
Language:EN
[2017/14]
Search report(s)International search report - published on:EP18.04.2013
ClassificationIPC:C07D307/22, C07D309/14, C07C255/58, A61K31/136, A61K31/341, A61K31/351, A61P21/00
[2014/34]
CPC:
C07D309/14 (EP,CN,US); C07C255/58 (EP,CN,US); A61P19/00 (EP);
A61P21/00 (EP); A61P21/06 (EP); A61P43/00 (EP);
A61P5/26 (EP); C07D307/22 (EP,CN,US); C07B2200/07 (EP,CN,US);
C07B2200/13 (EP,CN,US); C07C2601/08 (EP,CN,US); C07C2601/14 (EP,CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/34]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:SELEKTIVE ANDROGENREZEPTORMODULATOREN[2014/34]
English:SELECTIVE ANDROGEN RECEPTOR MODULATORS[2014/34]
French:MODULATEURS SÉLECTIFS D'UN RÉCEPTEUR DES ANDROGÈNES[2014/34]
Entry into regional phase13.05.2014National basic fee paid 
13.05.2014Designation fee(s) paid 
13.05.2014Examination fee paid 
Examination procedure11.04.2014Amendment by applicant (claims and/or description)
13.05.2014Examination requested  [2014/34]
06.05.2015Despatch of a communication from the examining division (Time limit: M04)
27.08.2015Reply to a communication from the examining division
23.11.2016Communication of intention to grant the patent
24.02.2017Fee for grant paid
24.02.2017Fee for publishing/printing paid
24.02.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.05.2015
Opposition(s)08.01.2018No opposition filed within time limit [2018/11]
Fees paidRenewal fee
31.10.2014Renewal fee patent year 03
02.11.2015Renewal fee patent year 04
31.10.2016Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.10.2012
AL05.04.2017
AT05.04.2017
CY05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
MC05.04.2017
MK05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
TR05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
LU05.10.2017
MT05.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
[2020/34]
Former [2020/15]HU05.10.2012
AT05.04.2017
CY05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
MC05.04.2017
MK05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
TR05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
LU05.10.2017
MT05.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2019/51]HU05.10.2012
AT05.04.2017
CY05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
MC05.04.2017
MK05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
LU05.10.2017
MT05.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2019/46]HU05.10.2012
AT05.04.2017
CY05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
MC05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
LU05.10.2017
MT05.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2019/31]HU05.10.2012
AT05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
MC05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
LU05.10.2017
MT05.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/43]AT05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
MC05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
LU05.10.2017
MT05.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/36]AT05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
MC05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
LU05.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/35]AT05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
MC05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
LU05.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/29]AT05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
MC05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
Former [2018/25]AT05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SI05.04.2017
SK05.04.2017
SM05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
Former [2018/11]AT05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SK05.04.2017
SM05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
Former [2018/10]AT05.04.2017
CZ05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
RO05.04.2017
RS05.04.2017
SE05.04.2017
SK05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
Former [2018/09]AT05.04.2017
DK05.04.2017
EE05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
RS05.04.2017
SE05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
Former [2017/50]AT05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
LV05.04.2017
RS05.04.2017
SE05.04.2017
BG05.07.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
Former [2017/49]AT05.04.2017
FI05.04.2017
HR05.04.2017
LT05.04.2017
NO05.07.2017
GR06.07.2017
IS05.08.2017
Cited inInternational search[A] WO2008130879  (SERENEX INC et al.)
 [AD] WO2006124447  (LILLY CO ELI et al.)
 [AD] WO2009105214  (RADIUS HEALTH INC et al.)
by applicantWO2009105214
 WO2006124447
   HAFER-MACKO ET AL., J. REHAB. RES. DEVELOP., vol. 45, no. 2, 2008, pages 261 - 272
   P. STAHL ET AL.: "Handbook of Pharmaceutical Salts: Properties, Selection and Use", 2011, WILEY-VCH
   S.M. BERGE ET AL.: "Pharmaceutical Salts", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 66, no. 1, January 1977 (1977-01-01), XP002675560, DOI: doi:10.1002/jps.2600660104

DOI:   http://dx.doi.org/10.1002/jps.2600660104
   "Remington: The Science and Practice of Pharmacy", 2005, MACK PUBLISHING CO.
   JACOBSEN, E. N ET AL., J. ORG. CHEM., vol. 62, 1997, pages 4197 - 4199
   ACIRO, C. ET AL., ORG. BIOMOL. CHEM., vol. 6, 2008, pages 3751 - 3761
   ACIRO, C. ET AL., ORG. BIOMOL. CHEM., vol. 6, 2008, pages 3762 - 3770
   BOND, C. W. ET AL., J. ORG. CHEM., vol. 74, 2009, pages 6735 - 6748
   FUNK, R. L. ET AL., TETRAHEDRON, vol. 41, 1985, pages 3479 - 3495
   WHITTEN, J. P.; MCCARTHY, J. R.; WHALON, M. R., J. ORG. CHEM., vol. 50, 1985, pages 4399 - 4402
   BLADES, K.; DONOHOE, T. J.; WINTER, J. J. G.; STEMP, G., TETRAHEDRON LETT., vol. 41, 2000, pages 4701 - 4704
   AUBE, J.; WOLFE, M.S.; YANTISS, R.K.; COOK, S.M.; TAKUSAGAWA, F., SYNTHETIC COMMUNICATIONS, vol. 22, 1992, pages 3003 - 3012
   JACOBSEN, E.N.; LARROW, J.F.; SCHAUS, S.E., J. ORG. CHEM., vol. 62, 1997, pages 4197 - 4199
   SHELDRICK, G. M., SHELXS86. ACTA CRYST., vol. A46, 1990, pages 467 - 473
   SHELDRICK, G. M., SHELXS93, 1993
   THE UNITED STATES PHARMACOPEIA #23, NATIONAL FORMULARY #18, 1995, pages 1843 - 1844
   NANTERMET P. ET AL., ENDOCRINOL, vol. 149, no. 4, pages 1551 - 1561
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.